Stock daily read

What happened with CRVL today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

CRVL in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

CorVel helps U.S. insurers, employers that fund their own insurance claims, claims administrators and government entities handle claims and the associated medical care. Most revenue comes from patient management: administering claims, coordinating injured employees’ treatment and rehabilitation, and helping them return to work. Customers pay for a complete claims-management program or selected services, chiefly for workers’ compensation but also for other insurance claims.

The other substantial revenue source is network solutions. CorVel reviews medical bills to identify potential savings and arranges care through provider networks, including its CareIQ directed-care network. These services help customers manage what they pay for treatment in workers’ compensation, auto and group-health claims. Proprietary claims and bill-review software supports the work.

The business depends on customers continuing to outsource claims work and on the volume of claims and medical care requiring its services, rather than on one dominant customer. Medical-review operations and provider networks must meet applicable state licensing and operating requirements. In reviewing whether treatment is appropriate, CorVel makes recommendations; it does not grant or deny benefit-payment claims.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in CRVL’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

CRVL says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

CorVel Corp’s results hinge on employers outsourcing workers’ compensation claims and on earning more per medical bill reviewed—not on insurance brokerage commissions or underwriting profits.

  • Crawford & Company’s Broadspire business competes with CorVel Corp for self-insured employers that pay outside providers to administer workers’ compensation claims, manage injured workers’ care and contain medical costs.

  • Arthur J. Gallagher & Co. and CorVel Corp both earn fees from self-insured organizations for administering and settling property-and-casualty claims. Watch Gallagher’s risk-management revenue for this overlap, rather than its insurance-placement business: risk management accounted for about 13% of its 2025 revenue, versus about 87% from brokerage.

  • ExlService Holdings, Inc. competes with CorVel Corp where insurers and healthcare payers hire outside firms to run claims operations and check medical payments for errors or overcharges; EXL’s services overlap with CorVel’s claims administration and medical bill review.

Agenda

in 7 daysTue, Oct 27

  1. Time to be announced

    ExlService Holdings, Inc. earningsEXLS

    ExlService Holdings, Inc.’s report will show whether insurers and healthcare payers are buying more outsourced claims operations and medical bill review, services that overlap with CorVel’s.

in 9 daysThu, Oct 29

  1. Time to be announced

    Arthur J. Gallagher & Co. earningsAJG

    Arthur J. Gallagher & Co.’s report will show whether its risk-management business is gaining or losing claims-administration work from self-insured organizations, a market it shares with CorVel.

in 13 daysMon, Nov 2

  1. Time to be announced

    Crawford & Company earningsCRD-A

    Crawford & Co.’s report will show whether its Broadspire business is gaining workers’ compensation claims and care-management work from self-insured employers, where it competes directly with CorVel.

in 14 daysTue, Nov 3

  1. Time to be announced
    Major

    Corvel Corp earningsThis company

    CorVel’s report will show whether customers are expanding enhanced bill review while its larger patient-management business keeps growing.